COVID-19 severity and mortality in multiple sclerosis do not depend on immunotherapy: a nation-wide Austrian registry

被引：0
|
作者：
Guger, M. [1 ]
Enzinger, C. [2 ]
Berger, T. [1 ]
Zulehner, G. [1 ]
Assar, H. [3 ]
Di Pauli, F. [7 ]
Gradl, C. [8 ]
Heschl, B. [2 ]
Hegen, H. [1 ]
Traxler, G. [1 ]
Rommer, P. [1 ]
Hiller, M. [1 ]
Kornek, B. [4 ]
Mayr, M. [1 ]
Morgenstern, G.
Schnabl, P.
Schneider-Koch, G. [5 ]
Zrzavy, T. [4 ,6 ]
Bsteh, G. [4 ]
机构：
[1] Kepler Univ Hosp GmbH, Clin Neurol 2, Med Campus 3, Linz, Austria
[2] Res Unit Neuronal Plast & Repair, Graz, Austria
[3] Kepler Univ Hosp, Dept Neurol, Linz, Austria
[4] Med Univ Vienna, Dept Neurol, Vienna, Austria
[5] Ottakring Hosp, Dept Neurol, Vienna, Austria
[6] Med Univ Innsbruck, Innsbruck, Austria
[7] Univ Klinikum St Polten, St Polten, Austria
[8] Krankenhaus Barmherzigen Bruder Eisenstadt, Eisenstadt, Austria
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR-066
引用
收藏
页码：249 / 250
页数：2
相关论文
共 50 条
  • [1] COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry
    Bsteh, Gabriel
    Assar, Hamid
    Hegen, Harald
    Heschl, Bettina
    Leutmezer, Fritz
    Di Pauli, Franziska
    Gradl, Christiane
    Traxler, Gerhard
    Zulehner, Gudrun
    Rommer, Paulus
    Wipfler, Peter
    Guger, Michael
    Enzinger, Christian
    Berger, Thomas
    [J]. PLOS ONE, 2021, 16 (07):
  • [2] COVID-19 severity and mortality in multiple sclerosis do not depend on immunotherapy: insights from a nationwide Austrian Registry
    Bsteh, G.
    Assar, H.
    Hegen, H.
    Heschl, B.
    Leutmezer, F.
    Di Pauli, F.
    Gradl, C.
    Traxler, G.
    Zulehner, G.
    Rommer, P.
    Wipfler, P.
    Guger, M.
    Enzinger, C.
    Berger, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 59 - 60
  • [3] COVID-19 in multiple sclerosis: update from the nation-wide Austrian registry
    Bsteh, G.
    Gradl, C.
    Assar, H.
    Heschl, B.
    Hegen, H.
    Di Pauli, F.
    Leutmezer, F.
    Traxler, G.
    Zulehner, G.
    Rommer, P.
    Hiller, M. -S.
    Krajnc, N.
    Wipfler, P.
    Guger, M.
    Enzinger, C.
    Berger, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 210 - 211
  • [4] Humoral immune response after COVID-19 in multiple sclerosis: a nation-wide Austrian study
    Bsteh, G.
    Duerauer, S.
    Assar, H.
    Hegen, H.
    Heschl, B.
    Leutmezer, F.
    Di Pauli, F.
    Gradl, C.
    Traxler, G.
    Zulehner, G.
    Rommer, P.
    Wipfler, P.
    Guger, M.
    Hoeftberger, R.
    Enzinger, C.
    Berger, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 752 - 753
  • [5] Humoral immune response after COVID-19 in multiple sclerosis: A nation-wide Austrian study
    Bsteh, Gabriel
    Duerauer, Sophie
    Assar, Hamid
    Hegen, Harald
    Heschl, Bettina
    Leutmezer, Fritz
    Di Pauli, Franziska
    Gradl, Christiane
    Traxler, Gerhard
    Zulehner, Gudrun
    Rommer, Paulus
    Wipfler, Peter
    Guger, Michael
    Hoeftberger, Romana
    Enzinger, Christian
    Berger, Thomas
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (14) : 2209 - 2218
  • [6] Long-term outcome after COVID-19 infection in multiple sclerosis: a matched-controlled study in a nation-wide Austrian registry
    Bsteh, G.
    Assar, H.
    Gradl, C.
    Heschl, B.
    Hiller, M. -S.
    Krajnc, N.
    Di Pauli, F.
    Hegen, H.
    Traxler, G.
    Wipfler, P.
    Guger, M.
    Enzinger, C.
    Berger, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 487 - 488
  • [7] Broadening the scope of nation-wide clinical registry for hospitalized COVID-19 patients
    Kumar, Sanjay
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2021, 153 (05) : 696 - 697
  • [8] COVID-19 prevalence and mortality in people with epilepsy: A nation-wide multicenter study
    Sanchez-Larsen, Alvaro
    Conde-Blanco, Estefania
    Viloria-Alebesque, Alejandro
    Sanchez-Vizcaino Buendia, Cristina
    Espinosa Oltra, Tatiana
    Alvarez-Noval, Amanda
    Aledo-Serrano, Angel
    Martin-Garcia, Raquel
    Ramos-Araque, Maria E.
    Campos, Dulce
    Valle-Penacoba, Gonzalo
    Sierra-Gomez, Alicia
    De Ceballos-Cerrajeria, Pablo
    Agundez-Sarasola, Marta
    Khawaja, Mariam
    Hampel, Kevin G.
    Serra-Martinez, Maria
    Arbos-Barber, Clara
    Gomez-Ibanez, Asier
    Villino-Boquete, Rafael
    Cabezudo-Garcia, Pablo
    Rodriguez-Lavado, Ignacio
    Principe, Alessandro
    Sopelana-Garay, David
    [J]. EPILEPSY & BEHAVIOR, 2021, 125
  • [9] Real life use of natalizumab and fingolimod - data from the nation-wide Austrian Multiple Sclerosis Treatment Registry
    Guger, M.
    Enzinger, C.
    Leutmezer, F.
    Kraus, J.
    Berger, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 315 - 316
  • [10] Broadening the scope of nation-wide clinical registry for hospitalized COVID-19 patients Reply
    Kumar, Gunjan
    Mukherjee, Aparna
    Sharma, Ravendra K.
    Menon, Geetha R.
    Sahu, Damodar
    Wig, Naveet
    Panda, Samiran
    Rao, Vishnu Vardhan
    Singh, Sujeet
    Guleriad, Randeep
    Bhargava, Balram
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2021, 153 (05) : 697 - 698
12345